Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioLeonhardt Whole Body is an active Leonhardt Ventures startup focused on whole-body regeneration and wellness-oriented bioelectric technologies. Its flagship commercial-facing product is BodStim, an EMS-based bioelectric bodysuit marketed to enhance exercise output, muscle activation, recovery, and overall wellness, while the broader long-term vision is a whole-body regeneration chamber that combines diagnostics, bioelectric mapping, and personalized regenerative protocols. The company describes a platform that uses wireless bioelectric stimulation, regenerative signaling, and in some cases adjunctive microinfusion, stem-cell-homing, and support-factor approaches to promote tissue repair and protein expression. Public materials indicate work around Klotho, follistatin, tropoelastin, SDF-1, VEGF, and other regenerative factors. The business appears to sit at the intersection of medtech, regenerative medicine, longevity, and wellness rather than a conventional clinical-stage biopharma model. Available evidence suggests it remains private, incubated within Leonhardt Ventures, and is still early stage overall.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioLeonhardt Whole Body.